Luigi Strizzi

Dr. Luigi Strizzi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GUGustavo Untiveros
Gustavo Untiveros
ARAleksandr Raskind
Aleksandr Raskind
LLLaura Linares
Laura Linares
ADAlessandro Dotti
Alessandro Dotti
LSLuigi Strizzi
Luigi Strizzi
Netrin-1 is a neural guidance factor that regulates migration and positioning of neural crest-derived cells during embryonic development. Depending on the type of Netrin-1 receptor expression, cells are either attracted or repulsed by Netrin-1. Postnatal expression of Netrin-1 is detected in brain, colon, liver, and kidney, which are common sites of cancer metastasis, including melanoma. Thus, understanding the dynamics between Netrin-1 and its receptors could explain the attraction of melanoma towards these Netrin-1-expressing tissues. Here, we investigate whether the Netrin-1-attractive receptor Neogenin can affect migration of melanoma cells towards a Netrin-1 source. Results from Western blot (WB) analysis show higher expression of Neogenin in aggressive compared to non-aggressive melanoma cells. Cell migration experiments show increased migration of Neogenin-expressing aggressive melanoma cells towards exogenous, soluble recombinant human Netrin-1 and towards a Netrin-1-expressing cell line. Furthermore, WB reveals ERK1/2 activation and increased N-cadherin expression in Neogenin-expressing aggressive melanoma cells treated with rhNetrin-1. Moreover, treatment with anti-Neogenin blocking antibody caused decreased migration towards Netrin-1-expressing cells and reduced ERK1/2 activity in Neogenin-expressing aggressive melanoma cells. These results suggest Neogenin may play a role during migration of melanoma cells towards Netrin-1 via ERK1/2 signaling.

1 July 2021 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
HDHussein Daraghma
Hussein Daraghma
GUGustavo Untiveros
Gustavo Untiveros
ARAleksandr Raskind
Aleksandr Raskind
EIEmanuela Iaccarino
Emanuela Iaccarino
Annamaria SandomenicoAnnamaria Sandomenico
Annamaria Sandomenico
LSLuigi Strizzi
Luigi Strizzi

Verified
Journal Article
Open access
PDF file
GUGustavo Untiveros
Gustavo Untiveros
LDLindsay Dezi
Lindsay Dezi
MGMegan Gillette
Megan Gillette
JSJulia Sidor
Julia Sidor
LSLuigi Strizzi
Luigi Strizzi
Melanoma is a lethal form of skin cancer triggered by genetic and environmental factors. Excision of early-stage, poorly aggressive melanoma often leads to a successful outcome; however, left undiagnosed these lesions can progress to metastatic disease. This research investigates whether the exposure of poorly aggressive melanoma to certain normal skin cells can explain how non-metastatic melanoma becomes more aggressive while still confined to the skin. To this end, we used a serial co-culture approach to sequentially expose cells from two different, poorly aggressive human melanoma cell lines against normal cells of the skin beginning with normal melanocytes, then epidermal keratinocytes, and finally dermal fibroblasts. Protein extraction of melanoma cells occurred at each step of the co-culture sequence for western blot (WB) analysis. In addition, morphological and functional changes were assessed to detect differences between the serially co-cultured melanoma cells and non-co-cultured cells. Results show that the co-cultured melanoma cells assumed a more mesenchymal morphology and displayed a significant increase in proliferation and invasiveness compared to control or reference cells. WB analysis of protein from the co-cultured melanoma cells showed increased expression of Snail and decreased levels of E-cadherin suggesting that epithelial-to-mesenchymal transition (EMT) is occurring in these co-cultured cells. Additional WB analysis showed increased levels of Nodal protein and signaling and signs of increased Wnt activity in the co-cultured melanoma cells compared to reference cells. These data suggest that interaction between poorly aggressive melanoma cells with normal cells of the skin may regulate the transition from localized, poorly aggressive melanoma to invasive, metastatic disease via Nodal and/or Wnt induced EMT.

Verified
Journal Article
Open access
PDF file
JSJulia Sidor
Julia Sidor
MGMegan Gillette
Megan Gillette
LDLindsay Ann Dezi
Lindsay Ann Dezi
GUGustavo Untiveros
Gustavo Untiveros
LSLuigi Strizzi
Luigi Strizzi
Presenilin-1 (PS-1), a component of the gamma (γ)-secretase catalytic complex, has been implicated in Alzheimer’s disease (AD) and in tumorigenesis. Interestingly, AD risk is inversely related to melanoma, suggesting that AD-related factors, such as PS-1, may affect melanomagenesis. PS-1 has been shown to reduce Wnt activity by promoting degradation of beta-catenin (β-catenin), an important Wnt signaling partner. Since Wnt is known to enhance progression of different cancers, including melanoma, we hypothesized that PS-1 could affect Wnt-associated melanoma aggressiveness. Western blot results showed that aggressive melanoma cells expressed significantly lower levels of both PS-1 and phosphorylated-β-catenin (P-β-catenin) than nonaggressive melanoma cells. Immunohistochemistry of human melanoma samples showed significantly reduced staining for PS-1 in advanced stage melanoma compared with early stage melanoma. Furthermore, γ-secretase inhibitor (GSI) treatment of aggressive melanoma cells was followed by significant increases in PS-1 and P-β-catenin levels, suggesting impaired Wnt signaling activity as PS-1 expression increased. Finally, a significant reduction in cell migration was associated with the higher levels of PS-1 and P-β-catenin in the GSI-treated aggressive melanoma cells. We demonstrate for the first time that PS-1 levels can be used to assess melanoma aggressiveness and suggest that by enhancing PS-1 expression, Wnt-dependent melanoma progression may be reduced

3 April 2023
Verified
Other
Open access
KHKatharine M. Hardy
Katharine M. Hardy
LSLuigi Strizzi
Luigi Strizzi
NMNaira Margaryan
Naira Margaryan
KGKanika Gupta
Kanika Gupta
GMGeorge F. Murphy
George F. Murphy
MHMary J.C. Hendrix
Mary J.C. Hendrix

3 April 2023
Verified
Other
Open access
KHKatharine M. Hardy
Katharine M. Hardy
LSLuigi Strizzi
Luigi Strizzi
NMNaira Margaryan
Naira Margaryan
KGKanika Gupta
Kanika Gupta
GMGeorge F. Murphy
George F. Murphy
MHMary J.C. Hendrix
Mary J.C. Hendrix